1 | group | 332,832 |
2 | phase-1 | 16 |
3 | sacc | 11 |
4 | ms4 | 9 |
5 | subproject | 8 |
6 | balozi | 6 |
7 | freak | 6 |
8 | dtgr | 5 |
9 | group’s | 5 |
10 | oncologia | 5 |
11 | effectiveness-alzheimer | 4 |
12 | 42b | 3 |
13 | 70/103 | 3 |
14 | dex- | 3 |
15 | group.we | 3 |
16 | rs753482aa | 3 |
17 | 1/75 | 2 |
18 | 54/244 | 2 |
19 | 60/103 | 2 |
20 | bamn | 2 |
21 | conditon | 2 |
22 | dianeal® | 2 |
23 | group-cg | 2 |
24 | group.4 | 2 |
25 | group=24 | 2 |
26 | hihb | 2 |
27 | intensiv | 2 |
28 | long-evans-tokushima-otsuka | 2 |
29 | nct00748488 | 2 |
30 | strata-adjusted | 2 |
31 | toucan | 2 |
32 | ul+re | 2 |
33 | -0.10±1.49 | 1 |
34 | -10.1+/-0.9 | 1 |
35 | 0.87+0.4 | 1 |
36 | 006653848 | 1 |
37 | 100-136 | 1 |
38 | 100:988-995 | 1 |
39 | 10·89 | 1 |
40 | 11/219 | 1 |
41 | 11:28±00:41 | 1 |
42 | 133+/-35.1mg/dl | 1 |
43 | 160.0+/-35.0 | 1 |
44 | 19.16±13.22 | 1 |
45 | 19.8+/-8.5 | 1 |
46 | 2.07±1.41 | 1 |
47 | 2.3±1.08 | 1 |
48 | 2/219 | 1 |
49 | 214±90 | 1 |
50 | 24.8±7.0 | 1 |
51 | 26+/-12.1mg/dl | 1 |
52 | 3.5+/-2.4 | 1 |
53 | 36.53±26.19 | 1 |
54 | 37.14±0.31 | 1 |
55 | 37.70±0.28 | 1 |
56 | 38.5±30.3 | 1 |
57 | 4.0±2.0 | 1 |
58 | 43/128 | 1 |
59 | 43/63 | 1 |
60 | 4868±345 | 1 |
61 | 5220±353 | 1 |
62 | 59.42±10.66 | 1 |
63 | 826.4 | 1 |
64 | 91.67±43.71 | 1 |
65 | adotropin | 1 |
66 | algorithms-empc | 1 |
67 | alpha-hydroxyesterone | 1 |
68 | andforty-one | 1 |
69 | arm-27 | 1 |
70 | arrowhead | 1 |
71 | biointerfaces | 1 |
72 | butyro-propionate | 1 |
73 | conditions.study | 1 |
74 | dayflower | 1 |
75 | diet+ldl-ab | 1 |
76 | diet-i | 1 |
77 | disease,3.create | 1 |
78 | e3/3-fh | 1 |
79 | eptiope | 1 |
80 | ethyl-eicosapentaenoate | 1 |
81 | feng'ao | 1 |
82 | fivefingers | 1 |
83 | froup | 1 |
84 | function-have | 1 |
85 | gauze-compressed | 1 |
86 | gold-a | 1 |
87 | group-22 | 1 |
88 | group-namely | 1 |
89 | group.before | 1 |
90 | group.furthermore | 1 |
91 | group/con | 1 |
92 | group25 | 1 |
93 | group=-0.24±1.50 | 1 |
94 | group=488 | 1 |
95 | group=93 | 1 |
96 | hcl-before | 1 |
97 | high-omega-3 | 1 |
98 | i-das | 1 |
99 | inf-alpha- | 1 |
100 | intake/d | 1 |
101 | lc/ec | 1 |
102 | makhana | 1 |
103 | mcie | 1 |
104 | metabolites—the | 1 |
105 | ml/bsa | 1 |
106 | n=5820 | 1 |
107 | n=8047 | 1 |
108 | nmol/5x10 | 1 |
109 | no-challenge | 1 |
110 | non-derepressible | 1 |
111 | nonrepressed | 1 |
112 | paricipants | 1 |
113 | patients-baseline | 1 |
114 | pi-/ | 1 |
115 | pld/pac/carbo | 1 |
116 | podhaler | 1 |
117 | reactor-r1 | 1 |
118 | smp1 | 1 |
119 | smp2 | 1 |
120 | smp3 | 1 |
121 | sputums | 1 |
122 | stramelopile | 1 |
123 | ta/carbograph | 1 |
124 | tofc | 1 |
125 | toothpaste.there | 1 |
126 | trial/rct | 1 |
127 | trivsel | 1 |
128 | twents | 1 |
1 | -0.10±1.49 | 1 |
2 | -10.1+/-0.9 | 1 |
3 | 0.87+0.4 | 1 |
4 | 006653848 | 1 |
5 | 1/75 | 2 |
6 | 100-136 | 1 |
7 | 100:988-995 | 1 |
8 | 10·89 | 1 |
9 | 11/219 | 1 |
10 | 11:28±00:41 | 1 |
11 | 133+/-35.1mg/dl | 1 |
12 | 160.0+/-35.0 | 1 |
13 | 19.16±13.22 | 1 |
14 | 19.8+/-8.5 | 1 |
15 | 2.07±1.41 | 1 |
16 | 2.3±1.08 | 1 |
17 | 2/219 | 1 |
18 | 214±90 | 1 |
19 | 24.8±7.0 | 1 |
20 | 26+/-12.1mg/dl | 1 |
21 | 3.5+/-2.4 | 1 |
22 | 36.53±26.19 | 1 |
23 | 37.14±0.31 | 1 |
24 | 37.70±0.28 | 1 |
25 | 38.5±30.3 | 1 |
26 | 4.0±2.0 | 1 |
27 | 42b | 3 |
28 | 43/128 | 1 |
29 | 43/63 | 1 |
30 | 4868±345 | 1 |
31 | 5220±353 | 1 |
32 | 54/244 | 2 |
33 | 59.42±10.66 | 1 |
34 | 60/103 | 2 |
35 | 70/103 | 3 |
36 | 826.4 | 1 |
37 | 91.67±43.71 | 1 |
38 | adotropin | 1 |
39 | algorithms-empc | 1 |
40 | alpha-hydroxyesterone | 1 |
41 | andforty-one | 1 |
42 | arm-27 | 1 |
43 | arrowhead | 1 |
44 | balozi | 6 |
45 | bamn | 2 |
46 | biointerfaces | 1 |
47 | butyro-propionate | 1 |
48 | conditions.study | 1 |
49 | conditon | 2 |
50 | dayflower | 1 |
51 | dex- | 3 |
52 | dianeal® | 2 |
53 | diet+ldl-ab | 1 |
54 | diet-i | 1 |
55 | disease,3.create | 1 |
56 | dtgr | 5 |
57 | e3/3-fh | 1 |
58 | effectiveness-alzheimer | 4 |
59 | eptiope | 1 |
60 | ethyl-eicosapentaenoate | 1 |
61 | feng'ao | 1 |
62 | fivefingers | 1 |
63 | freak | 6 |
64 | froup | 1 |
65 | function-have | 1 |
66 | gauze-compressed | 1 |
67 | gold-a | 1 |
68 | group | 332,832 |
69 | group-22 | 1 |
70 | group-cg | 2 |
71 | group-namely | 1 |
72 | group.4 | 2 |
73 | group.before | 1 |
74 | group.furthermore | 1 |
75 | group.we | 3 |
76 | group/con | 1 |
77 | group25 | 1 |
78 | group=-0.24±1.50 | 1 |
79 | group=24 | 2 |
80 | group=488 | 1 |
81 | group=93 | 1 |
82 | group’s | 5 |
83 | hcl-before | 1 |
84 | high-omega-3 | 1 |
85 | hihb | 2 |
86 | i-das | 1 |
87 | inf-alpha- | 1 |
88 | intake/d | 1 |
89 | intensiv | 2 |
90 | lc/ec | 1 |
91 | long-evans-tokushima-otsuka | 2 |
92 | makhana | 1 |
93 | mcie | 1 |
94 | metabolites—the | 1 |
95 | ml/bsa | 1 |
96 | ms4 | 9 |
97 | n=5820 | 1 |
98 | n=8047 | 1 |
99 | nct00748488 | 2 |
100 | nmol/5x10 | 1 |
101 | no-challenge | 1 |
102 | non-derepressible | 1 |
103 | nonrepressed | 1 |
104 | oncologia | 5 |
105 | paricipants | 1 |
106 | patients-baseline | 1 |
107 | phase-1 | 16 |
108 | pi-/ | 1 |
109 | pld/pac/carbo | 1 |
110 | podhaler | 1 |
111 | reactor-r1 | 1 |
112 | rs753482aa | 3 |
113 | sacc | 11 |
114 | smp1 | 1 |
115 | smp2 | 1 |
116 | smp3 | 1 |
117 | sputums | 1 |
118 | stramelopile | 1 |
119 | strata-adjusted | 2 |
120 | subproject | 8 |
121 | ta/carbograph | 1 |
122 | tofc | 1 |
123 | toothpaste.there | 1 |
124 | toucan | 2 |
125 | trial/rct | 1 |
126 | trivsel | 1 |
127 | twents | 1 |
128 | ul+re | 2 |
1 | inf-alpha- | 1 |
2 | dex- | 3 |
3 | pi-/ | 1 |
4 | 4.0±2.0 | 1 |
5 | 160.0+/-35.0 | 1 |
6 | 24.8±7.0 | 1 |
7 | nmol/5x10 | 1 |
8 | n=5820 | 1 |
9 | group=-0.24±1.50 | 1 |
10 | 214±90 | 1 |
11 | phase-1 | 16 |
12 | 37.14±0.31 | 1 |
13 | 2.07±1.41 | 1 |
14 | 11:28±00:41 | 1 |
15 | 91.67±43.71 | 1 |
16 | smp1 | 1 |
17 | reactor-r1 | 1 |
18 | group-22 | 1 |
19 | 19.16±13.22 | 1 |
20 | smp2 | 1 |
21 | high-omega-3 | 1 |
22 | 38.5±30.3 | 1 |
23 | 60/103 | 2 |
24 | 70/103 | 3 |
25 | 5220±353 | 1 |
26 | 43/63 | 1 |
27 | group=93 | 1 |
28 | smp3 | 1 |
29 | 0.87+0.4 | 1 |
30 | 3.5+/-2.4 | 1 |
31 | 826.4 | 1 |
32 | group.4 | 2 |
33 | group=24 | 2 |
34 | 54/244 | 2 |
35 | ms4 | 9 |
36 | 19.8+/-8.5 | 1 |
37 | group25 | 1 |
38 | 4868±345 | 1 |
39 | 1/75 | 2 |
40 | 100:988-995 | 1 |
41 | 100-136 | 1 |
42 | 59.42±10.66 | 1 |
43 | arm-27 | 1 |
44 | n=8047 | 1 |
45 | 2.3±1.08 | 1 |
46 | 37.70±0.28 | 1 |
47 | 43/128 | 1 |
48 | 006653848 | 1 |
49 | nct00748488 | 2 |
50 | group=488 | 1 |
51 | -10.1+/-0.9 | 1 |
52 | 36.53±26.19 | 1 |
53 | 11/219 | 1 |
54 | 2/219 | 1 |
55 | -0.10±1.49 | 1 |
56 | 10·89 | 1 |
57 | gold-a | 1 |
58 | rs753482aa | 3 |
59 | oncologia | 5 |
60 | long-evans-tokushima-otsuka | 2 |
61 | makhana | 1 |
62 | ml/bsa | 1 |
63 | 42b | 3 |
64 | diet+ldl-ab | 1 |
65 | hihb | 2 |
66 | sacc | 11 |
67 | lc/ec | 1 |
68 | tofc | 1 |
69 | algorithms-empc | 1 |
70 | intake/d | 1 |
71 | arrowhead | 1 |
72 | nonrepressed | 1 |
73 | gauze-compressed | 1 |
74 | strata-adjusted | 2 |
75 | no-challenge | 1 |
76 | metabolites—the | 1 |
77 | mcie | 1 |
78 | non-derepressible | 1 |
79 | stramelopile | 1 |
80 | patients-baseline | 1 |
81 | andforty-one | 1 |
82 | alpha-hydroxyesterone | 1 |
83 | eptiope | 1 |
84 | ul+re | 2 |
85 | toothpaste.there | 1 |
86 | hcl-before | 1 |
87 | group.before | 1 |
88 | group.furthermore | 1 |
89 | disease,3.create | 1 |
90 | butyro-propionate | 1 |
91 | ethyl-eicosapentaenoate | 1 |
92 | function-have | 1 |
93 | group.we | 3 |
94 | group-cg | 2 |
95 | e3/3-fh | 1 |
96 | ta/carbograph | 1 |
97 | diet-i | 1 |
98 | balozi | 6 |
99 | freak | 6 |
100 | 26+/-12.1mg/dl | 1 |
101 | 133+/-35.1mg/dl | 1 |
102 | trivsel | 1 |
103 | toucan | 2 |
104 | adotropin | 1 |
105 | bamn | 2 |
106 | group/con | 1 |
107 | conditon | 2 |
108 | feng'ao | 1 |
109 | pld/pac/carbo | 1 |
110 | froup | 1 |
111 | group | 332,832 |
112 | podhaler | 1 |
113 | effectiveness-alzheimer | 4 |
114 | dayflower | 1 |
115 | dtgr | 5 |
116 | i-das | 1 |
117 | biointerfaces | 1 |
118 | sputums | 1 |
119 | fivefingers | 1 |
120 | paricipants | 1 |
121 | twents | 1 |
122 | group’s | 5 |
123 | subproject | 8 |
124 | trial/rct | 1 |
125 | intensiv | 2 |
126 | conditions.study | 1 |
127 | group-namely | 1 |
128 | dianeal® | 2 |